WallStSmart

Lineage, Inc. Common Stock (LINE)vsCorporación Inmobiliaria Vesta, S.A.B de C.V. (VTMX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 1730% more annual revenue ($5.36B vs $292.84M). VTMX leads profitability with a 112.0% profit margin vs -2.7%. VTMX earns a higher WallStSmart Score of 60/100 (C+).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

VTMX

Buy

60

out of 100

Grade: C+

Growth: 8.0Profit: 8.0Value: 5.7Quality: 7.5
Piotroski: 4/9Altman Z: 1.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

VTMXSignificantly Overvalued (-65.6%)

Margin of Safety

-65.6%

Fair Value

$19.91

Current Price

$34.95

$15.04 premium

UndervaluedFair: $19.91Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

VTMX4 strengths · Avg: 10.0/10
P/E RatioValuation
9.2x10/10

Attractively priced relative to earnings

Profit MarginProfitability
112.0%10/10

Keeps 112 of every $100 in revenue as profit

Operating MarginProfitability
77.6%10/10

Strong operational efficiency at 77.6%

EPS GrowthGrowth
584.0%10/10

Earnings expanding 584.0% YoY

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

VTMX2 concerns · Avg: 4.0/10
Price/BookValuation
10.3x4/10

Trading at 10.3x book value

Altman Z-ScoreHealth
1.704/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : VTMX

The strongest argument for VTMX centers on P/E Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 112.0% and operating margin at 77.6%. Revenue growth of 14.3% demonstrates continued momentum.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : VTMX

The primary concerns for VTMX are Price/Book, Altman Z-Score.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while VTMX is a mature play — different risk/reward profiles.

VTMX is growing revenue faster at 14.3% — sustainability is the question.

VTMX generates stronger free cash flow (11M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VTMX scores higher overall (60/100 vs 34/100), backed by strong 112.0% margins and 14.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.

Visit Website →

Corporación Inmobiliaria Vesta, S.A.B de C.V.

REAL ESTATE · REAL ESTATE - DEVELOPMENT · USA

Corporacin Inmobiliaria Vesta, S.A.B. de C.V., acquires, develops, manages, operates, and leases industrial buildings and distribution centers in Mexico. The company is headquartered in Mexico City, Mexico.

Visit Website →

Want to dig deeper into these stocks?